TP53 and diffuse large B-cell lymphoma: Recent studies demonstrate that the cytotoxicity of APR-246 (eprenetapopt), a prodrug that binds mutant TP53, is iron-dependent and can be prevented by iron chelators or inhibitors of lipid peroxidation, but not necroptosis, pyroptosis or apoptosis inhibitors in DLBCL cells [85].